United States Nuclear Medicine & Radio Pharmaceuticals Market Report 2017

In this report, the United States Nuclear Medicine & Radio Pharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Nuclear Medicine & Radio Pharmaceuticals in these regions, from 2012 to 2022 (forecast).

United States Nuclear Medicine & Radio Pharmaceuticals market competition by top manufacturers/players, with Nuclear Medicine & Radio Pharmaceuticals sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
GE Healthcare
Philips Healthcare
Siemens Healthcare
Toshiba
Hitachi
Carestream
Esaote
Shimadzu
TriFoil Imaging
Biosensors International Group, Ltd

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Diagnostic Applications: SPECT, PET.
Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Nuclear Medicine & Radio Pharmaceuticals Market Report 2017
1 Nuclear Medicine & Radio Pharmaceuticals Overview
1.1 Product Overview and Scope of Nuclear Medicine & Radio Pharmaceuticals
1.2 Classification of Nuclear Medicine & Radio Pharmaceuticals by Product Category
1.2.1 United States Nuclear Medicine & Radio Pharmaceuticals Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Nuclear Medicine & Radio Pharmaceuticals Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
1.2.4 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
1.3 United States Nuclear Medicine & Radio Pharmaceuticals Market by Application/End Users
1.3.1 United States Nuclear Medicine & Radio Pharmaceuticals Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Diagnostic Applications: SPECT, PET.
1.3.3 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
1.4 United States Nuclear Medicine & Radio Pharmaceuticals Market by Region
1.4.1 United States Nuclear Medicine & Radio Pharmaceuticals Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2022)
1.4.3 Southwest Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2022)
1.4.5 New England Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2022)
1.4.6 The South Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2022)
1.4.7 The Midwest Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Nuclear Medicine & Radio Pharmaceuticals (2012-2022)
1.5.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2012-2022)
1.5.2 United States Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2012-2022)

2 United States Nuclear Medicine & Radio Pharmaceuticals Market Competition by Players/Suppliers
2.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Nuclear Medicine & Radio Pharmaceuticals Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Nuclear Medicine & Radio Pharmaceuticals Average Price by Players/Suppliers (2012-2017)
2.4 United States Nuclear Medicine & Radio Pharmaceuticals Market Competitive Situation and Trends
2.4.1 United States Nuclear Medicine & Radio Pharmaceuticals Market Concentration Rate
2.4.2 United States Nuclear Medicine & Radio Pharmaceuticals Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Nuclear Medicine & Radio Pharmaceuticals Manufacturing Base Distribution, Sales Area, Product Type

3 United States Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Region (2012-2017)
3.2 United States Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Region (2012-2017)
3.3 United States Nuclear Medicine & Radio Pharmaceuticals Price by Region (2012-2017)

4 United States Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Type (2012-2017)
4.3 United States Nuclear Medicine & Radio Pharmaceuticals Price by Type (2012-2017)
4.4 United States Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate by Type (2012-2017)

5 United States Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) by Application (2012-2017)
5.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Application (2012-2017)
5.2 United States Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Nuclear Medicine & Radio Pharmaceuticals Players/Suppliers Profiles and Sales Data
6.1 GE Healthcare
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Philips Healthcare
6.2.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Siemens Healthcare
6.3.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Toshiba
6.4.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Hitachi
6.5.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Carestream
6.6.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Carestream Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Esaote
6.7.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Esaote Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Shimadzu
6.8.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 TriFoil Imaging
6.9.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Biosensors International Group, Ltd
6.10.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Nuclear Medicine & Radio Pharmaceuticals Manufacturing Cost Analysis
7.1 Nuclear Medicine & Radio Pharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Nuclear Medicine & Radio Pharmaceuticals Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Nuclear Medicine & Radio Pharmaceuticals Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume Forecast by Type (2017-2022)
11.3 United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume Forecast by Application (2017-2022)
11.4 United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer




List of Tables and Figures

Figure Product Picture of Nuclear Medicine & Radio Pharmaceuticals
Figure United States Nuclear Medicine & Radio Pharmaceuticals Market Size (K Units) by Type (2012-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Type (Product Category) in 2016
Figure Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Product Picture
Figure Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Product Picture
Figure United States Nuclear Medicine & Radio Pharmaceuticals Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Nuclear Medicine & Radio Pharmaceuticals by Application in 2016
Figure Diagnostic Applications: SPECT, PET. Examples
Table Key Downstream Customer in Diagnostic Applications: SPECT, PET.
Figure Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. Examples
Table Key Downstream Customer in Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
Figure United States Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) by Region (2012-2022)
Figure The West Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Nuclear Medicine & Radio Pharmaceuticals Sales Share by Players/Suppliers
Figure 2017 United States Nuclear Medicine & Radio Pharmaceuticals Sales Share by Players/Suppliers
Figure United States Nuclear Medicine & Radio Pharmaceuticals Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Players/Suppliers
Figure 2017 United States Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Players/Suppliers
Table United States Market Nuclear Medicine & Radio Pharmaceuticals Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Nuclear Medicine & Radio Pharmaceuticals Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Nuclear Medicine & Radio Pharmaceuticals Market Share of Top 3 Players/Suppliers
Figure United States Nuclear Medicine & Radio Pharmaceuticals Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Nuclear Medicine & Radio Pharmaceuticals Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Nuclear Medicine & Radio Pharmaceuticals Product Category
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) by Region (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Share by Region (2012-2017)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Share by Region (2012-2017)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Region in 2016
Table United States Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Region (2012-2017)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Region (2012-2017)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Region in 2016
Table United States Nuclear Medicine & Radio Pharmaceuticals Price (USD/Unit) by Region (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) by Type (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Share by Type (2012-2017)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Share by Type (2012-2017)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Type in 2016
Table United States Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nuclear Medicine & Radio Pharmaceuticals by Type (2012-2017)
Figure Revenue Market Share of Nuclear Medicine & Radio Pharmaceuticals by Type in 2016
Table United States Nuclear Medicine & Radio Pharmaceuticals Price (USD/Unit) by Types (2012-2017)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate by Type (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) by Application (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2012-2017)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2012-2017)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application in 2016
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate by Application (2012-2017)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate by Application (2012-2017)
Table GE Healthcare Basic Information List
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2012-2017)
Figure GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in United States (2012-2017)
Figure GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in United States (2012-2017)
Table Philips Healthcare Basic Information List
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2012-2017)
Figure Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in United States (2012-2017)
Figure Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in United States (2012-2017)
Table Siemens Healthcare Basic Information List
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2012-2017)
Figure Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in United States (2012-2017)
Figure Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in United States (2012-2017)
Table Toshiba Basic Information List
Table Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2012-2017)
Figure Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in United States (2012-2017)
Figure Toshiba Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in United States (2012-2017)
Table Hitachi Basic Information List
Table Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2012-2017)
Figure Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in United States (2012-2017)
Figure Hitachi Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in United States (2012-2017)
Table Carestream Basic Information List
Table Carestream Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Carestream Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2012-2017)
Figure Carestream Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in United States (2012-2017)
Figure Carestream Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in United States (2012-2017)
Table Esaote Basic Information List
Table Esaote Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Esaote Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2012-2017)
Figure Esaote Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in United States (2012-2017)
Figure Esaote Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in United States (2012-2017)
Table Shimadzu Basic Information List
Table Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2012-2017)
Figure Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in United States (2012-2017)
Figure Shimadzu Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in United States (2012-2017)
Table TriFoil Imaging Basic Information List
Table TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2012-2017)
Figure TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in United States (2012-2017)
Figure TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in United States (2012-2017)
Table Biosensors International Group, Ltd Basic Information List
Table Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2012-2017)
Figure Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in United States (2012-2017)
Figure Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine & Radio Pharmaceuticals
Figure Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals
Figure Nuclear Medicine & Radio Pharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Medicine & Radio Pharmaceuticals Major Players/Suppliers in 2016
Table Major Buyers of Nuclear Medicine & Radio Pharmaceuticals
Table Distributors/Traders List
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) Forecast by Type in 2022
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) Forecast by Application in 2022
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume Share Forecast by Region (2017-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume Share Forecast by Region (2017-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Golf Cart Market is Projected to Exhibit a CAGR of 5.95% During the Forecast Period 2017-2025

Published Date : Jul 2018

According to the new market research report ""Golf Cart Market, by Component (Electric Golf Carts and Gasoline Golf Carts), by End Users (Private and Government), by Product Type (Electric Golf Carts and Gasoline Golf Carts), By Seating Capacity (Small (2-4), Medium (6-8), and Large (10+)), and by G...

Honeycomb Packaging Market Is Registering a Highest Growth with a CAGR of 6.5% Over the Forecast Period 2017-2025

Published Date : Jul 2018

The global honeycomb packaging market was valued at US$ 9.64 Bn in 2016 and is expected to reach US$ 16.95 Bn by 2025, registering a CAGR of 6.5% over the forecast period (2017-2025) according to a Honeycomb Packaging Market, by Packaging Type (Exterior Packaging, Interior packaging, Pallets, and Ot...

Pigment Market is Expected to Reach US$ 29,954.0 Mn Witnessing a CAGR of 4.25% During Forecast Period 2017-2025

Published Date : Jul 2018

The global pigments market was valued at US$ 20,695.4 Mn in 2016 and is expected to reach US$ 29,954.0 Mn by 2025, witnessing a CAGR of 4.25% over the forecast period (2017-2025) according to that Pigments Market, by Product Type (Inorganic, Organic, and Specialty Pigments), by End-use industry (Aut...

Agricultural Biological Market is Expected to Grow at a CAGR of 14.1% from 2017 Till 2025

Published Date : Jul 2018

The agricultural biological market was valued at US$ 5.99 Billion in 2016 and is projected to reach US$ 21.25 billion by 2025, exhibiting a CAGR of 15% during the forecast period, according to Agricultural Biological Market, by product type (Biopesticides, Biofertilizers, and Biostimulants) by Sourc...

Global Nuclear Fuel Transportation Container Market Research Report 2018

Published Date : Jul 2018

Nuclear Fuel Transportation Container Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries ...

Offshore Wind Market By Technological Advancements & Competitive Insights From 2017 to 2025

Published Date : Jul 2018

Global Industrial market was valued at US$ 23.29 Billion in 2016, according to Global Offshore Wind Market Report by Location (Deep-water (depth >60 m), Transitional Water (depth 30-60 m), and Shallow water (depth < 30 m)), by Component (Substructure, Turbine, Electrical Infrastructure, and Others),...

Medical Robotic System Market - Analysis by Product Type, Construction Industry, Regions from 2017-2025

Published Date : Jul 2018

The Global Medical Robotic System Market, by Product Type (Instruments & Accessories and Medical Robotic Systems), by Medical Robotic Systems (Surgical Robots (Orthopedic Robotic Systems, Neurosurgery Robotic Systems, General Laparoscopy Robotic Systems, and Robotic Catheters/ Steerable Catheters), ...

Cognitive system Market - Analysis by Market Drivers, Trends, Applications & Business Strategy Forecast 2017-2025

Published Date : Jul 2018

According to the new market research report ""Cognitive system Market by Deployment Model (Cloud, On-Premises), by Technology ( machine learning, natural language processing, planning and scheduling), by End Users (banking, education, government, healthcare, insurance, manufacturing, security and in...

Advanced Biofuel Market - Analysis By Size, Share, Emerging Trends, Analysis and Forecasts 2017-2025

Published Date : Jul 2018

The Global Advanced Biofuel Market was valued at US$ 8.880 billion in 2016 and is expected to reach US$ 194.633 billion by 2025 growing at a CAGR of 41.18% over the forecast period. According to an Advanced Biofuel Market Report, by Fuel Type (Cellulosic Ethanol, Biofuel, Biobutanol, BioDME, and oth...

Xanthan Gum Market - Market Shares, Strategies and Forecasts, Analysis 2017-2025

Published Date : Jul 2018

The global Xanthan Gum market was valued at US$ 383.0 million in 2016, according to Global Xanthan Gum Market Report, by Form (Dry & Liquid), by Function (Thickeners, Stabilizers, Fat Replacers, Coating Materials, Gelling Agents, and Others), and by End-use Industry (Food & Beverages, Pharmaceutical...

 

Select Licence :

  • Single User : $3800
  • Corporate User : $7600

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.